Anne Tybjærg‐Hansen

University of Copenhagen — Denmark

Medicine · Health Sciences

118h-index66.1kcitations589works5.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(148), Diabetes, Cardiovascular Risks, and Lipoproteins(126), Genetic Associations and Epidemiology(77), Liver Disease Diagnosis and Treatment(65), Cancer, Lipids, and Metabolism(51)

Publications559 total

Metabolic dysfunction-associated steatotic liver disease, cardiometabolic risk factors, and cardiovascular disease
Atherosclerosis·2025· 1 citedOpen Access
Cholesterol‐lowering drug targets reduce risk of dementia: Mendelian randomization and meta‐analyses of 1 million individuals
Alzheimer s & Dementia·2025· 1 citedOpen Access
Repurposing statin treatment for the prevention of gallstone disease
Atherosclerosis·2025· 1 citedOpen Access
Metabolic syndrome and risk of vascular-related dementia in high-risk and low-risk prospective cohorts
Atherosclerosis·2025Open Access
Lipoprotein(a) and recurrent atherosclerotic cardiovascular disease events by sex and race/ethnicity and use of LDL cholesterol lowering therapy: A cohort study from the US family heart database
Atherosclerosis·2025Open Access
Target Populations for Novel Triglyceride-Lowering Therapies
Journal of the American College of Cardiology·2025· 25 cited
Loss-of-Function in APOC3 and Protection Against Aortic Valve Disease
Journal of the American College of Cardiology·2025
Cardiovascular diseases and risk of dementia in the general population
European Journal of Preventive Cardiology·2025· 4 citedOpen Access
VLDL triglycerides and cholesterol in non-alcoholic fatty liver disease and myocardial infarction
Atherosclerosis·2024· 3 citedOpen Access
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
The Lancet Diabetes & Endocrinology·2024· 10 citedOpen Access
<i>European Heart Journal</i>: a call to action
European Heart Journal·2024· 1 citedOpen Access
Polygenic risk of high LDL cholesterol and ischemic heart disease in the general population
Atherosclerosis·2024· 4 citedOpen Access
Cardiovascular diseases and risk of dementia in the general population
Atherosclerosis·2024Open Access
Cardiovascular risk factors and risk of vascular-related dementia in high-risk and low-risk prospective cohort studies
Atherosclerosis·2024· 2 citedOpen Access
Cardiovascular risk factors and aortic valve stenosis: towards 10-year absolute risk charts for primary prevention
European Journal of Preventive Cardiology·2024· 9 cited
Actionability and familial uptake following opportunistic genomic screening in a pediatric cancer cohort
European Journal of Human Genetics·2024· 3 citedOpen Access
First genome-wide association study of plasma transthyretin concentration PB68 (#203)
2024
Does <i>SLC39A8</i> Ala391Thr Confer Risk of Chronic Liver Disease?
Antioxidants and Redox Signaling·2024· 3 cited
Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis
Nature Genetics·2024· 46 citedOpen Access
Polygenic risk scores for cardiovascular risk prediction: moving towards implementation into clinical practice?
European Heart Journal·2024· 3 citedOpen Access
page 1 of 28Next →

Frequent Co-authors

Børge G. Nordestgaard(43), Gerald F. Watts(11), Marianne Benn(11), Henry N. Ginsberg(10), Olivier Descamps(9), Jan Borén(9), Alberico L. Catapano(9), Marja‐Riitta Taskinen(9), L. Masana(8), Robert A. Hegele(8), Petri T. Kovanen(8), Jan Albert Kuivenhoven(8), Kausik K. Ray(8), Erik S.G. Stroes(8), Frederick J. Raal(7), Maurizio Averna(7), John Danesh(7), George Davey Smith(6), Steve E. Humphries(6), Olov Wiklund(6)